Inspira Technologies Oxy B H N Ltd's Competitiveness
A competitive positioning analysis and financial ratio benchmarking of Inspira Technologies Oxy B H N Ltd (IINN) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.
Key Findings: Inspira Technologies Oxy B H N Ltd vs Its Competitors
- TTM: Trailing 12-month revenue of 0M vs 155M combined for its competitors (0.2% combined share).
- Trending: Latest-quarter revenue run-rate is decelerating (-338.1% annualized vs trailing 12 months), vs decelerating (-40.8%) for its tracked peer group.
Every figure above is sourced and cited in detail further down this page (Market Structure, Profitability & Cost Structure, Productivity vs Peers).
API endpoints for this dataset
Inspira Technologies Oxy B H N Ltd vs. its Competitors, Q4 2024
Revenue run-rate vs trailing 12 months
TTM net margin
TTM = trailing twelve months. Run-rate annualizes the latest quarter (×4) and compares it to TTM. In millions of $. High-Confidence Competitors are named as a competitor directly in Inspira Technologies Oxy B H N Ltd reports; Similar-Size Competitors are the closest peers by market-cap rank within the same industry; Similar Growth & Profitability Competitors are the closest peers by combined revenue growth, operating margin and ROIC, all independent of the competitor list.
TTM revenue, latest-quarter run-rate and net income/margin benchmarked across Inspira Technologies Oxy B H N Ltd and its 4 competitor groupings. Available under Commercial License.
| Entity | TTM Revenue | Rev Run-rate vs TTM |
|---|---|---|
| Inspira Technologies Oxy B H N Ltd | $12,345M | +12.3% · Accelerating |
| Competitors combined | $12,345M | +12.3% · Accelerating |
| High-Confidence Competitors (6) | $12,345M | +12.3% · Accelerating |
TTM revenue, run-rate and net margin benchmarking across Inspira Technologies Oxy B H N Ltd's competitor groups requires a Commercial License.
Inspira Technologies Oxy B H N Ltd's Competitor Quality Breadth
Group definitions: see Methodology: Performance Group Definitions.
| Entity | Profitable | Expanding | Above Industry Growth | Distressed |
|---|---|---|---|---|
| Inspira Technologies Oxy B H N Ltd | - | - | - | Yes |
| Competitors combined (1) | ||||
| High-Confidence Competitors (6) |
Source: CSIMarket API, trailing 12 months. Altman Z-Score is not shown here: it is not populated in the underlying data for any company. Percentages are of companies in each group that report the relevant metric, not of the full group size.
IINN Stock Performance relative to its Competitors
IINN Stock Performance relative to High-Confidence Competitors
5 Best-Performing Tracked Competitors, Trailing 12 Months
| # | Competitor | TTM Share Price Return | vs U.S.A. 500 |
|---|---|---|---|
| 1 | Neuronetics Inc | 282.9% | Outperformed |
TTM share price return and U.S.A. 500 outperformance for Inspira Technologies Oxy B H N Ltd's best-performing competitors requires a Commercial License.
Source: CSIMarket API, trailing 12 months.
Inspira Technologies Oxy B H N Ltd's Comment on Competition and Industry Peers
Publicly Traded Peers of Inspira Technologies Oxy B H N Ltd
Revenue and income for trailing 12 months, in millions of $, except employees| Company | Market Cap | Revenues |
|---|---|---|
 Inspira Technologies Oxy B H N Ltd |
47.69 | 0.29 |
 Neuronetics Inc |
146.99 | 154.59 |
| SUBTOTAL | 194.68 | 154.88 |
Sources: see Methodology: Peer & Competitor Identification, Sourcing.
Updated on:
Focus of this report: publicly traded companies. Ten additional tables on Inspira Technologies Oxy B H N Ltd versus competitors, including market share analysis, are in the navigation menu under Competition. To download the tables, please subscribe.
Inspira Technologies Oxy B H N Ltd's Competitors Named by the Company
Competitive relationships identified from Inspira Technologies Oxy B H N Ltd reports and corroborating sources, each with a basis and confidence.| Competitor | Basis | Confidence |
|---|---|---|
| Drägerwerk AG & Co. KGaA | Company report | 85% |
| Philips Healthcare | Company report | 85% |
| Boston Scientific Corporation | Company report | 85% |
| Masimo Corporation | Company report | 85% |
| Fisher & Paykel Healthcare Corporation Limited | Company report | 85% |
| ResMed Inc. | Company report | 85% |
| Chart Industries, Inc. | Company report | 85% |
| Medtronic plc | Company report | 85% |
| Becton, Dickinson and Company | Company report | 85% |
| Hamilton Medical AG | Company report | 85% |
| Smiths Medical Inc. | Company report | 85% |
Company report basis, confidence, active dates and source counts for Inspira Technologies Oxy B H N Ltd's named competitors require a Commercial License.
Methodology: see Methodology: Peer & Competitor Identification, Sourcing.
Inspira Technologies Oxy B H N Ltd's Business Segment Mix vs Peers
Revenue by operating segment or division, as named and reported by each company. Segment names are the filer's own and are not standardized across companies. Do not assume a same-named or similarly-named segment is defined identically between two companies. Shares are of each company's own total revenue and are not required to sum to 100% (intersegment revenue, unallocated items).| Company | Largest Segment |
|---|---|
| Neuronetics Inc | Greenbrook Segment 62.27 % |
Source: operating segment revenue as reported in each company's reports (10-K/10-Q), via the CSIMarket API, leaf-level reportable segments only (parent roll-up segments are excluded where sub-segments are separately disclosed).
Inspira Technologies Oxy B H N Ltd's Productivity vs Peers Comparison
Revenue and income per employee, trailing 12 months, in $; market cap in millions of $| Company | Market Cap | Revenue / Employee | Income / Employee |
|---|---|---|---|
| Inspira Technologies Oxy B H N Ltd | 48 | - | - |
| Neuronetics Inc | 147 | 234,945 | -46,886 |
| PEERS TOTAL | 147 | 234,945 | -46,886 |
Inspira Technologies Oxy B H N Ltd's Position in Industry Market Structure
Market-capitalization share and concentration across all 218 companies in Inspira Technologies Oxy B H N Ltd's industry classification, broader than the peer set above. Market cap in millions of $.Inspira Technologies Oxy B H N Ltd ranks #0 of 218 companies by market capitalization in its industry, holding 0.00 % of total industry market cap. The industry's Herfindahl-Hirschman Index (HHI) is 605, indicating a unconcentrated market structure (see Methodology: Market Structure & Concentration).
| Rank | Company | Market Cap | Industry Share |
|---|---|---|---|
| 1 | Intuitive Surgical Inc | 160,799 | 13.27 % |
| 2 | Medtronic Plc | 130,553 | 10.77 % |
| 3 | Stryker Corp | 125,176 | 10.33 % |
| 4 | 3m Company | 98,927 | 8.16 % |
| 5 | Boston Scientific Corporation | 1,234 | 5.2% |
| 6 | Edwards Lifesciences Corporation | 1,234 | 5.2% |
| 7 | Becton Dickinson And Company | 1,234 | 5.2% |
| 8 | Alcon inc | 1,234 | 5.2% |
| 9 | Medline Inc | 1,234 | 5.2% |
| 10 | Resmed Inc | 1,234 | 5.2% |
| 0 | Inspira Technologies Oxy B H N Ltd | 23 | 0.00 % |
Market cap and industry share for the rest of Inspira Technologies Oxy B H N Ltd's industry peers requires a Commercial License.
Source: CSIMarket API (daily market-structure computation) across CSIMarket's industry classification, market capitalization as of 2026-07-17.
Inspira Technologies Oxy B H N Ltd's Profitability & Cost Structure
Trailing 12-month margins from SEC-filed financials. Operating margin is compared to the Medical Equipment & Supplies industry median; gross margin, EBITDA margin and capital intensity are compared to the live industry average (342 companies). See the full Medical Equipment & Supplies industry profitability benchmarks.| Metric | Company | Industry | Difference |
|---|---|---|---|
| Gross Margin | 0.69 % | 46.20 % (avg) | -45.5 pp |
| Operating Margin | - | industry median | - |
| EBITDA Margin | - | -6.66 % (avg) | - |
| Capital Intensity (Capex / Revenue) | 35.64 % | 7.13 % (avg) | +28.5 pp |
Source: CSIMarket API, trailing 12 months. SG&A and R&D as a share of revenue have limited coverage as this data is backfilled and appear only where reported. Higher capital intensity is not inherently negative; it reflects the industry's asset requirements.
Inspira Technologies Oxy B H N Ltd's Multi-Year Financial Trajectory
Fiscal-year revenue growth, operating margin, return on invested capital and P/E, as reported in company reports.| Metric | 2023 | 2024 | 2025 |
|---|---|---|---|
| Revenue Growth | - | - | - |
| Operating Margin | - | - | - |
| Return on Invested Capital | -94.71 % | -124.88 % | -271.16 % |
| P/E | - | - | - |
Source: CSIMarket API, fiscal-year figures. P/E is this company's own historical ratio at each fiscal year end and can swing sharply around an earnings trough: that is real, not a data error.
Inspira Technologies Oxy B H N Ltd's Competitive Forces (Porter's Five Forces)
Only the forces this data can support honestly are shown; the other three are marked as such rather than guessed.| Force | Assessment | Basis |
|---|---|---|
| Competitive Rivalry | High | Industry HHI of 605 (see Industry Market Structure & Concentration above) |
| Barriers to Entry | High (capital intensive) | Capital intensity (capex / revenue) of 35.64 % vs industry average 7.13 % (see Profitability & Cost Structure above) |
Note: see Methodology: Porter's Five Forces. Supplier power and buyer power are covered on Inspira Technologies Oxy B H N Ltd's dedicated Suppliers and Customers pages, not here.
Inspira Technologies Oxy B H N Ltd's SWOT
Every point below is a fixed rule applied to a metric already shown elsewhere on this page (Market Structure, Profitability, Valuation, Run-Rate, Stock Performance, Quality Breadth) not an independent strategic assessment. A blank quadrant means no rule was met, not that none apply.Strengths
No rule matched.
Weaknesses
- Return on equity 577.4 points below the industry aggregate.
- Latest-quarter revenue run-rate is decelerating (-338.1% annualized vs trailing 12 months).
- Piotroski F-Score of 2 or below, the standard financial-distress signal.
Opportunities
No rule matched.
Threats
- Tracked peer group's revenue run-rate is broadly decelerating (-40.8% annualized).
- High capital intensity requires continuous reinvestment just to keep pace with the industry.
Methodology: see Methodology: SWOT Analysis.
Inspira Technologies Oxy B H N Ltd's Financial Strength vs Peers Comparison
Quick ratio, working capital, debt to equity and asset turnover, trailing 12 months| Company | Quick Ratio | Working Capital | Debt / Equity |
|---|---|---|---|
| Inspira Technologies Oxy B H N Ltd | 2.27 | 1.56 | - |
| Neuronetics Inc | 0.97 | 1.95 | 2.68 |
Quick ratio = cash / current liabilities; working capital ratio = current assets / current liabilities; asset turnover = revenue / total assets. Peers in the Blank Checks industry are excluded.
Inspira Technologies Oxy B H N Ltd's Revenue and Income Growth vs Peers
Quarterly revenue and net income growth, year over year and quarter over quarter| Company | Period | Revenue Y/Y | Income Y/Y |
|---|---|---|---|
| Inspira Technologies Oxy B H N Ltd | Q4 2024 | - | - |
| Neuronetics Inc | Q2 2026 | +10.2 % | - |
| PEERS TOTAL | +11.0 % | - |
Growth is shown only where both periods are positive. Peers in the Blank Checks industry are excluded.
Inspira Technologies Oxy B H N Ltd's Peers' Costs of Sales and Capital Expenditures
Context for revenue growth: peer costs and capex, year over year and quarter over quarter| Company | Period | Costs Y/Y | Capex Y/Y |
|---|---|---|---|
| Inspira Technologies Oxy B H N Ltd | Q4 2024 | +5,820.0 % | -37.2 % |
| Neuronetics Inc | Q2 2026 | +1.7 % | +65.5 % |
Inspira Technologies Oxy B H N Ltd's Returns and Turnover vs Peers
ROA, ROI and ROE (trailing 12 months), receivables and inventory turnover| Company | ROA | ROI | ROE |
|---|---|---|---|
| Inspira Technologies Oxy B H N Ltd | - | - | - |
| Neuronetics Inc | - | - | - |
ROA = net income / total assets; ROI = net income / investments; ROE = net income / equity; turnover ratios use trailing 12 month revenue (receivables) and cost of sales (inventory).
Inspira Technologies Oxy B H N Ltd's Valuation vs Peers
P/E, price to sales, PEG, price to cash flow and price to book| Company | P/E | Price / Sales |
|---|---|---|
| Inspira Technologies Oxy B H N Ltd | - | 165.03 |
| Neuronetics Inc | - | 0.95 |
| PEERS AVERAGE | - | 1.26 |
P/E = price / diluted EPS (trailing 12 months); PEG = P/E divided by EPS growth; the average row divides the peers' combined market cap by their combined income, sales, cash flow and equity.